Skip to Main Content
Who We Are
Back
Overview
Mission
Board
Medical Advisory Committee
Research Advisory Committee
Program Committee
Staff
Founders
Funding Partners
Blood Disorders
News
Join Us
Back
Membership Overview
Events
Newsletter
Education
Back
Overview
Archived Webinars, Symposia, and Workshops
Case Conversation Series
Learning Module: Clinical Strategies for Managing HMB
Curricula
FWGBD Biennial Conference
Upcoming Symposia
FWGBD 2026
Back
Overview
Registration
Jeanette Doner Mann Travel Awards
Resources
Back
7-2-1 Podcast
Animations
Ask-the-Experts
Autoimmune Hemolytic Anemia (AIHA) Resource Center
Clinics
Genetics
Guidelines, Screening Tools & Recommendations
Immune Thrombocytopenia Resources
Provider Handouts
Patient Resources
Period Talk Toolkit
Resource Library
Networks
Back
WGBD® Clinics of Excellence
LAN Overview
Current WGBD® LAN Members
Current WGSCD™ LAN Members
Research & Workforce Development
Back
Workforce Overview
Research Fellowship Awards
FWGBD Research Grant Award
FWGBD Annual Research Grant Awards
FWGBD Special Research Grant Awards
Past Award Winners
Search
youtube
Donate
Resources
Filter by:
Topic
Topic
2025 Must-Read
Acquired Hemophilia
Anemias
Bleeding Disorders
Cardiovascular Health
Clotting & Clotting Disorders
Factor IX Deficiency
Factor VIII Deficiency
Fertility
Heavy Menstrual Bleeding
Hemophilia
Hypermobility Spectrum Disorders
Immune Thrombocytopenia (ITP)
Iron Disorders
LAN Developed
Myelodysplastic Syndromes
Other Blood Disorders
Platelets
Pregnancy and Postpartum
Recommendations & Guidelines
Sickle Cell Disease
Von Willebrand Disease
WGBD Clinics (LAN)
Workforce Development
Type
Type
Article
Link
Video
Year
Year
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Keyword search
Search
Hormonal therapies in females with blood disorders: thrombophilia, thrombosis, hemoglobinopathies and anemias
Baldwin MK, Bannow BS, Rosovsky RP, Sokkary N, Srivaths L
Article
May 2023
Anemias
Clotting & Clotting Disorders
LAN Developed
Platelets
Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study
Khalighi, M, Wheeler, AP, Adeyemi-Fowode, OA, Kouides, PA, Durazo-Arvizu, RA, Haley, KM, Dersch, CM, Weyand, AC, Baldwin, MK, and Borzutzky, C
Article
April 2022
Heavy Menstrual Bleeding
LAN Developed
Is ≥ 100% the magic number to rule out the laboratory diagnosis of von Willebrand disease based on initial testing?
Weyand AC, Kouides P, Malvar J, Jaffray J.
Link
August 2021
LAN Developed
Von Willebrand Disease
Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease
Pecker LH, Sharma D, Nero A, Paidas MJ, Ware RE, James AH, and Smith-Whitley K
Article
July 2021
LAN Developed
Pregnancy and Postpartum
Sickle Cell Disease
Workforce Development
Provider Attitudes and Practices Regarding Intrauterine System (IUS) Insertion in Adolescents With and Without Bleeding Disorders for Management of Heavy Menstrual Bleeding
O’Flynn O’Brien K, Wheeler AP, Borzutzky C, Haley KM, Kouides P, and Adeymei-Fowode O
Article
January 2021
Bleeding Disorders
Heavy Menstrual Bleeding
LAN Developed
The Discordance between Offsite to Onsite Testing for Von Willebrand Disease in Post-Menarchal Females: A Multi-Center Study
Jaffray, J, Sidonio, RF, Malvar, J, Staber, JM, Haley, KM, Stillings, A, Weyand, AC, O'Brien, S, and Kouides, PA
Article
November 2019
LAN Developed
Von Willebrand Disease
left
1
2